202 related articles for article (PubMed ID: 3041097)
1. Reduction of proteinuria by angiotensin converting enzyme inhibition.
Heeg JE; de Jong PE; van der Hem GK; de Zeeuw D
Kidney Int; 1987 Jul; 32(1):78-83. PubMed ID: 3041097
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition.
Heeg JE; de Jong PE; van der Hem GK; de Zeeuw D
Kidney Int; 1991 Oct; 40(4):734-41. PubMed ID: 1660550
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.
Heeg JE; de Jong PE; van der Hem GK; de Zeeuw D
Kidney Int; 1989 Aug; 36(2):272-9. PubMed ID: 2550696
[TBL] [Abstract][Full Text] [Related]
4. Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action.
Heeg JE; de Jong PE; de Zeeuw D
Clin Sci (Lond); 1991 Sep; 81(3):367-72. PubMed ID: 1655338
[TBL] [Abstract][Full Text] [Related]
5. Effect of lisinopril monotherapy on renal hemodynamics.
Reams GP; Bauer JH
Am J Kidney Dis; 1988 Jun; 11(6):499-507. PubMed ID: 2837083
[TBL] [Abstract][Full Text] [Related]
6. Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril.
Heeg JE; de Jong PE; Vriesendorp R; de Zeeuw D
Am J Nephrol; 1990; 10 Suppl 1():94-7. PubMed ID: 2175149
[TBL] [Abstract][Full Text] [Related]
7. Add-on angiotensin receptor blockade with maximized ACE inhibition.
Agarwal R
Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
August P; Cody RJ; Sealey JE; Laragh JH
Am J Hypertens; 1989 Aug; 2(8):599-603. PubMed ID: 2550029
[TBL] [Abstract][Full Text] [Related]
9. Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function.
Palla R; Panichi V; Finato V; Parrini M; Andreini B; Bianchi AM; Giovannini L; Migliori M; Bertelli AA
Int J Clin Pharmacol Res; 1994; 14(1):35-43. PubMed ID: 7927959
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH
Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585
[TBL] [Abstract][Full Text] [Related]
12. Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study.
Janssen JJ; Gans RO; van der Meulen J; Pijpers R; ter Wee PM
Am J Hypertens; 1998 Sep; 11(9):1074-9. PubMed ID: 9752892
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease.
Watson ML; Macnicol AM; Allan PL; Wright AF
Kidney Int; 1992 Jan; 41(1):206-10. PubMed ID: 1317477
[TBL] [Abstract][Full Text] [Related]
14. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.
Remuzzi A; Imberti O; Puntorieri S; Malanchini B; Macconi D; Magrini L; Bertani T; Remuzzi G
Am J Physiol; 1994 Dec; 267(6 Pt 2):F1034-44. PubMed ID: 7528985
[TBL] [Abstract][Full Text] [Related]
16. The effects of lisinopril on renal function in proteinuric renal transplant recipients.
Traindl O; Falger S; Reading S; Banyai M; Liebisch B; Gisinger J; Templ E; Mayer G; Kovarik J
Transplantation; 1993 Jun; 55(6):1309-13. PubMed ID: 8390733
[TBL] [Abstract][Full Text] [Related]
17. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
Tylicki L; Rutkowski P; Renke M; Rutkowski B
Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
[TBL] [Abstract][Full Text] [Related]
19. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
Osterziel KJ; Nagel F; Dietz R
Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286
[TBL] [Abstract][Full Text] [Related]
20. Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitor.
Erley CM; Harrer U; Krämer BK; Risler T
Kidney Int; 1992 May; 41(5):1297-303. PubMed ID: 1614045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
